Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The new technology allows for standardized, electronic reports after surgeries, improving data analysis and patient outcomes. It has been adopted by the Alberta Cancer Board and other health regions, tracking surgical effectiveness and resource allocation.
A recent study found that major pancreatic cancer surgery can be successfully performed on patients in their 80s, 90s, and older with comparable five-year survival rates to the general population. This challenges common misconceptions about the suitability of elderly patients for such surgery.
A pilot study found that folic acid supplementation significantly increased mean folate levels and decreased homocysteine levels, leading to complete resolution of leucoplakia lesions in 28% of patients. The results suggest folate may effectively reduce cancer progression risk, especially in those with hypofolatemia.
The Vera Bradley Foundation has donated $6.8M to the IU Breast Cancer Research Program, supporting groundbreaking research and improving treatment outcomes for patients. The gift is the foundation's 13th major donation to IU School of Medicine and marks a continued commitment to finding a cure for breast cancer.
A study published in the Journal of the National Cancer Institute found that screening for lung cancer can lead to overdiagnosis, resulting in unnecessary treatment and harm. The study suggests that mass screening may not be beneficial for public health due to the potential for overdiagnosis bias.
A randomized, controlled study found that exercise reduced cancer-related fatigue and improved strength during radiation treatment, with participants taking at least 12,000 steps per day. The study showed that moderate physical activity resulted in significant improvements in aerobic capacity and reduced fatigue.
Researchers have introduced a new technique combining SPECT and spiral CT for improved bone scanning, shortening diagnostic time and clarifying findings. The technology has been shown to enhance the specificity of bone scintigraphy and reduce CT radiation exposure.
Researchers have discovered a new biomarker, ICAM, that can predict lung cancer treatment response and survival. Patients with low levels of ICAM had a higher response rate to treatment and significantly better overall survival rates.
Research highlights continued health risks following surgery, particularly for patients with serious underlying diseases. By understanding the mechanisms of inflammation and adopting strategies such as minimizing surgical incisions and pre-surgery medication, healthcare teams can reduce these risks.
A study found that patients with advanced liver, gallbladder, and bile duct cancers who developed a skin rash while treated with lapatinib lived for an average of 10 months, compared to five months for those without the rash. The treatment was well-tolerated, with two patients experiencing partial responses to treatment.
A new combination therapy after surgery has improved survival rates for pancreatic cancer patients by 50%, increasing median survival from 16.9 to 20.6 months. The study found significant benefits for patients with pancreatic head adenocarcinoma, a type of cancer that affects the pancreas.
A new study confirms that, despite an increase in hospice care, many terminally ill cancer patients continue to receive aggressive treatment in the last days of life. The study found that while hospice use increased steadily over time, it was often not used for symptom relief and building relationships.
A five-year update from the IRIS Study Group shows excellent results for people with Chronic Myelogenous Leukemia (CML) treated with Gleevec, a targeted cancer therapy. Overall survival rates reach 89% at five years, with fewer than 1% of patients progressing to accelerated or blast crisis phases.
The ASCO and ESMO have released a consensus statement outlining 10 essential components of quality cancer care, aiming to address inequalities in healthcare systems worldwide. The document highlights the importance of informed consent, multidisciplinary care teams, and access to innovative treatments for patients diagnosed with cancer.
A randomized trial involving 250 patients with advanced prostate cancer found that high-dose calcitriol (DN-101) significantly reduced venous and arterial thromboses compared to a placebo. This unexpected benefit offers an avenue of investigation for improved safety in various cancers.
A study in Queensland, Australia found that Indigenous patients had lower survival rates and fewer cases of early-stage cancer compared to non-Indigenous patients. The researchers highlight the need for holistic and culturally respectful approaches to address these disparities.
Long-term cancer survivors experience ongoing concerns about cancer recurrence and treatment side effects, affecting their mental health. Research found that these worries are linked to depression and anxiety, with varying levels of concern across different types of cancer.
A study analyzed data from over 35,975 individuals who underwent colonoscopy without detecting colorectal neoplasia. The results showed a significant decrease in colorectal cancer incidence at 6 months (31%) and persisted for more than 10 years. A negative colonoscopy was associated with a lower risk of developing CRC.
Research suggests that diabetes may be a marker of early pancreatic cancer, with studies showing increased rates of colon, pancreatic, and esophageal cancers in patients with diabetes. Additionally, women with type 2 diabetes are at higher risk of developing colorectal adenomas and advanced adenoma.
A new study from the University of Michigan finds that patients often struggle to access reliable medical information online. Librarians play a crucial role in helping patients find quality resources, providing expertise and accessing specialized databases not available to the general public.
A new blood test measures the rate of nicotine metabolism to predict quitting success, distinguishing smokers who need higher doses of nicotine or alternative therapies. The study used saliva samples from 480 smokers and found a link between rapid metabolism and increased craving.
The IU Cancer Center will attract top-tier scientists and physicians with the gift, enhancing its national reputation as a leader in cancer research and patient care. The center's research and clinical programs are expanding, and partnerships are increasing to achieve goals.
The NYU algorithm uses Bayesian statistics to pinpoint tumor suppressor genes in cancer genomes. By analyzing segmental deletions and spatial relations, the algorithm detects genes that were previously unknown or overlooked.
A study found that lobular breast cancer (ILC) and ductal breast cancer (IDC) have similar success rates for breast-conserving therapy. ILC patients had larger tumors, but the success rate did not differ between groups.
Researchers evaluated 92 patients with bladder cancers using MDCT and found 87 tumors, regardless of whether contrast was used. They also discovered that new CT technology can scan rapidly enough to evaluate the bladder fully, potentially obviating the need for invasive cystoscopy.
Researchers have identified a biological marker that predicts persistent fatigue in breast cancer survivors, attributed to inflammation. The biomarker combines immune response elements, including interleukin-6 receptor and T cells with CD69 protein.
Patients who never smoked showed improved response to chemotherapy and longer survival rates compared to former and current smokers. The finding may be attributed to non-smokers having less genetic damage and better preserved lung function.
A study by Wake Forest Baptist suggests that all tumors spreading from the appendix are cancer, regardless of microscopic appearance. Patients with low-grade variant have high survival rates when treated with surgery and chemotherapy.
Researchers argue that surgery is most effective approach in many patients, improving five-year survival rates compared to chemotherapy and radiation. The study found that en bloc esophagectomy results in fewer cancer deaths than transhiatal resection.
The study reveals high molecular heterogeneity in multiple myeloma, with new recurrent amplifications and deletions pointing to yet-to-be-discovered oncogenes and tumor suppressor genes. These findings define new disease subgroups with distinct clinical outcomes and potential therapeutic implications.
Researchers have identified a potential new treatment for malignant gliomas using bortezomib, which targets the NF-kB pathway to induce cell death. This discovery builds on previous studies showing that selective estrogen receptor modulators (SERMs) can also induce cell death in brain cancers.
Researchers identify mutation in JAK2 signaling pathway, allowing cells to bypass normal red blood-cell production process. This discovery could lead to the development of targeted treatments that improve treatment outcomes for patients with PV disease.
Researchers discovered four protein biomarkers that can predict death from colorectal cancer independent of stage or location. A micro-RNA signature also predicts colon cancer development by regulating gene expression and cellular pathways.
A large clinical trial of low-dose isotretinoin in early-stage head and neck cancer patients found no reduction in second primary tumors or improved survival. Current smokers had increased rates of second primary tumors and death, highlighting the importance of smoking cessation.
Researchers have developed novel diagnostic tests for lung cancer using airway gene expression assays, which identified three times as many early-stage cancers as conventional bronchoscopy. Genetic signatures from epithelial cells complement clinical results to diagnose 95% of patients with lung cancer.
Panitumumab significantly improves progression-free survival and disease control in patients with mCRC, with a median duration of response of 17 weeks. The treatment was well-tolerated, with few major adverse reactions.
Researchers found a significant increase in cancer risk among first-degree relatives of lung cancer patients, particularly young onset cancers. The study's findings suggest that genetic factors play a crucial role in the development of lung cancer and other types of cancer.
A new study comparing healthcare systems in Australia and the US found that young patients are more likely to survive cancer in Australia due to universal health insurance. The US system, which relies on private insurance, leads to a higher mortality rate among teenagers and young adults.
Experts warn that doctors must discuss future fertility with young cancer patients to provide truly informed consent. Current data indicate room for improvement in fertility counselling, with only 34% of patients receiving pre-treatment advice.
The UK's first Professor of Teenage and Young Adult Cancer emphasizes the need for improved communication and coordination among pediatricians, oncologists, and other healthcare professionals. Currently, TYA cancer patients often receive sub-standard treatment due to fragmented care.
A lack of specialist training for nurses is failing adolescent cancer patients, according to a nurse manager at the Manchester Teenage Cancer Trust Unit. The unique needs of teenagers and young adults with cancer require expertise in disease management, symptom control, and psychosocial issues.
AACR Public Service Awards recognize Sherry Lansing and Janet Woodcock's dedication to advancing cancer research. Lansing, former Paramount CEO, has raised millions for cancer research through her non-profit advocacy group Stop Cancer, while Woodcock, FDA deputy commissioner, streamlines cancer medicine oversight.
The American Association for Cancer Research (AACR) is launching a new magazine, CR, to address the public's need for understandable information about cancer research and policy. The magazine aims to put a human face on cancer research by sharing stories of survivors and their experiences.
Researchers report three cases of advanced cancers with long survival times after high-dose intravenous vitamin C therapy. The study suggests that high-dose intravenous vitamin C should be reassessed as a potential cancer treatment option.
Dr. Bernard Fisher's pioneering research on tumor metastasis and clinical trials has transformed the management of breast cancer. His systematic studies revealed that a combination of lumpectomy and radiation therapy is equally effective as total mastectomy, changing the way physicians approach patient care.
A study by U-M researchers found that patients with delayed surgery (more than 93 days) had worse survival rates and lower three-year survival rates compared to those with timely surgery. Scheduling issues were the most common cause of delay, which can lead to micrometastases and poor outcomes.
Patients undergoing more extensive (D3) lymph node dissection had higher 5-year overall survival rates compared to those with less extensive (D1) surgery. D3 nodal dissection offers a survival benefit when performed by experienced surgeons.
The new web resource provides instant access to cancer information materials in 11 Asian languages, including Chinese, Korean, and Vietnamese. The site features over 12 organizations' contributions, with all materials reviewed for medical accuracy and cultural relevance.
Two new studies reveal laparoscopic surgery is as safe as traditional laparotomy for uterine cancer patients, with a significant reduction in hospital stay and improved quality of life. The studies also show that laparoscopy results in less pain, faster recovery, and better body image.
A new dictionary of terms has been developed to convert medical jargon into everyday speech, helping patients understand their breast cancer experience. The French dictionary, which will be bilingual, aims to bridge the language gap between patients and doctors.
A recent study published in Psychology of Addictive Behaviors found that nearly half of smokers made false assumptions about the tar content of Quest cigarettes, a low-nicotine brand. Smokers who felt less vulnerable to health effects and didn't think critically also made more false inferences about the potential harms.
The American Association for Cancer Research (AACR) has conferred its highest honors to several scientists for their groundbreaking contributions to cancer research. Carlo Croce and Wiliam Kaelin received awards for their pioneering work in leukemia and lymphoma research, while Julian Adams was recognized for his discovery of the first...
Protein sorting in pigment cells plays a crucial role in the development of diseases such as melanoma and Alzheimer's. The study reveals that Pmel17 proteins are sorted to the melanosome through endosomes, similar to other amyloid proteins.
A new automatic system at the Ann Arbor VA hospital kept eight patients with serious scan results from falling through the cracks, including five who had cancer. The system, which uses electronic tags to alert doctors to potential problems, was developed after a similar issue occurred at the institution.
A randomized Phase III clinical trial found decitabine improved treatment outcomes for myelodysplastic syndrome patients, achieving a 17% complete response rate. The median time to progression was also significantly longer in treated patients compared to those receiving supportive care.
Researchers found that retreatment with decitabine resulted in 45% of patients achieving any response, with some experiencing partial or complete remission. The median overall survival was 28 months, and continued outpatient maintenance treatment is being studied for its benefits.
A study found that internet use increases feelings of control among cancer patients, allowing them to view their relationship with doctors as a partnership. Online access also enables patients to make informed decisions about their treatment.
A recent study found that 67% of teenage and young adult cancer patients successfully banked their sperm, despite initial obstacles such as anxiety and lack of knowledge. The researchers emphasized the importance of incorporating fertility preservation into treatment plans for these patients.
A new study by Johns Hopkins Medicine found that men with low-grade prostate cancer who receive active surveillance may not be at increased risk of noncurable prostate cancer. The study compared outcomes in men who delayed surgery for two years to those who underwent immediate treatment, finding no significant difference in risk.
Researchers identified a specific protein pattern that can distinguish bladder cancer patients from healthy controls and others with similar symptoms. This discovery has the potential to predict tumour stage, recurrence, progression, and treatment response in bladder cancer patients.